BMS Expands its Existing Patient Support Programs to Aid Uninsured Patients in the US Amid COVID-19
BMS Reports Results of Triple Regimen in P-III ELOQUENT-1 Study for Patients with Newly Diagnosed Untreated Multiple Myeloma
Shots:
- The expanded program offers access to any branded BMS’s therapies for free, including its most widely prescribed therapies and those prescribed via telehealth services
- Patients can reach to BMS’ patient support programs by calling it on (800) 721-8909 or by visiting BMS.com.
- The program provides immediate access for patients who have lost their employment and health insurance, includes a single point of entry, streamlined enrollment process and a voucher to assist with continuity of care for self-administered BMS therapies
Click here to read full press release/ article | Ref: BMS | Image: BMS